COSENTYX subst sèche 150 mg flac
7680632950015
CH-63295
L04AC10
07.15.0.
Reimbursement limitations:
COSENTYX.01
Psoriasis en plaques sévère
Cosentyx est indiqué pour le traitement des patients adultes et pédiatriques …
1 / 2
google
Details
- Product number
- 6329501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: secukinumabum 150 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, pro vitro.
Articles (1)
Cosentyx 150 mg, Pulver zur Herstellung einer Injektionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HIMDK |
|
PRC
|
- | Substance | HIMDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 602.45
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2017
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 63295
- Drug name
- Cosentyx, Pulver zur Herstellung einer Injektionslösung
- Galenic form
- PULVL
- ATC Code
- L04AC10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/02/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- COSENTYX subst sèche 150 mg flac
- Description (DE)
- COSENTYX Trockensub 150 mg Durchstf
- Market launch
- 20/02/2015
- Narcotic (BTM)
- No